MediPrint Ophthalmics Presents Phase 2b LL-BMT1 Data for Glaucoma
12 Nov 2024 //
BUSINESSWIRE
MediPrint Ophthalmics Announces It Has Initiated Its SIGHT-2 Phase 2b
08 Nov 2022 //
BUSINESSWIRE
12 Nov 2024 //
BUSINESSWIRE
08 Nov 2022 //
BUSINESSWIRE